News for Healthier Living

Novel CAR-T Therapy for Hard-to-Treat Multiple Myeloma Shows Promising Safety and Durable Responses

A phase 1 clinical trial found that an investigational CAR-T therapy can lead to deep and durable responses in people with relapsed or refractory multiple myeloma.

September 30, 2026


October 1 2026

September 30 2026

September 29 2026

September 28 2026

September 27 2026

September 25 2026

September 24 2026

September 23 2026

September 22 2026

September 21 2026

September 18 2026

September 17 2026